Lipid Disorder: Clinical Trials

3 trials for Lipid Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 1, Completed 1, Recruiting 1

Follow Lipid Disorder: new trials by email Literature Review of Lipid Disorder trials Research Report on Lipid Disorder

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
Statin (rosuvastatin 10 or 40 mg daily, depending on risk), Healthy Lifestyle Counseling, Outpatient Followup - Lipid Disorder, Hypercholesterolemia
Phase 2RecruitingWake Forest University Health Sciences1302024-08-052026-02-27
Polypill in Acute Coronary Syndrome
Polypill, Usual Care (individual medications prescribed by primary cardiologist) - Acute Coronary Syndrome, Lipid Disorder
Phase 2CompletedUniversity of Texas Southwestern Medical Center1402022-11-302026-09-22
Causal Mechanisms in Adolescent Arterial Stiffness
CS+, CS- - Lipid Disorder, Dyslipidemias
Phase 2Active not recruitingBaylor College of Medicine902020-02-012025-12-10

Narrower conditions

Lipid Metabolism Disorders (3)  ·  Acute Coronary Syndrome (1)  ·  Atherosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Artery Disease (1)  ·  Dyslipidemias (1)  ·  Hypercholesterolemia (1)  ·  Hyperlipidemias (1)  ·  Insulin Resistance (1)  ·  Metabolic Syndrome (1)  ·  Pediatric Obesity (1)

Broader conditions

Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Arterial Occlusive Diseases (2)  ·  Arteriosclerosis (2)  ·  Vascular Diseases (2)  ·  Body Weight (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Disease (1)  ·  Dyslipidemias (1)  ·  Glucose Metabolism Disorders (1)  ·  Heart Diseases (1)  ·  Hyperinsulinism (1)  ·  Myocardial Ischemia (1)  ·  Nutrition Disorders (1)  ·  Obesity (1)

Interventions

Hydroxymethylglutaryl-CoA Reductase Inhibitors (1)  ·  Rosuvastatin Calcium (1)

Sponsors

Baylor College of Medicine (1)  ·  University of Texas Southwestern Medical Center (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (3)

Top investigators

Ambarish Pandey, MD, MSCS (1)  ·  Justin P Zachariah, MD MPH (1)  ·  Nick Ashburn (1)

NIH funding

K23HL169929 (1), R01HL148217 (1)